Detalles de la búsqueda
1.
DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma.
BMC Cancer
; 16: 21, 2016 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26772812
2.
Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction.
Cancer Immunol Immunother
; 63(12): 1273-84, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25164876
3.
Response to reintroduction of cetuximab in 5 patients with advanced, chemotherapy-resistant, colorectal cancer without progressive disease following first-line therapy with a cetuximab-containing regimen.
Oncology
; 74(3-4): 123-6, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18708729
4.
[Problems and chances of the application of systemically acting drugs via the lung]. / Möglichkeiten und Probleme der Applikation von systemisch wirksamen, höhermolekularen Wirkstoffen mittels Inhalation.
Med Klin (Munich)
; 101(9): 718-23, 2006 Sep 15.
Artículo
en Alemán
| MEDLINE | ID: mdl-16977396
5.
Tracheal and bronchial involvement in colitis ulcerosa - a colo-bronchitic syndrome? A case report and some additional considerations.
Ger Med Sci
; 13: Doc03, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25834480
6.
A phase I/II study of oxaliplatin and paclitaxel in patients with non-resectable cancer of the oesophagus and adenocarcinoma of the gastro-oesophageal junction: a study of the Arbeitsgemeinschaft Internistische Onkologie.
Cancer Chemother Pharmacol
; 66(1): 191-5, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20354701
Resultados
1 -
6
de 6
1
Próxima >
>>